4‐Aminopyridinium 4‐aminobenzoate dihydrate and 4‐aminopyridinium nicotinate

In the title compounds, 4‐aminopyridinium 4‐aminobenzoate dihydrate, C₇H₆NO₂⁻·C₅H₇N₂⁺·2H₂O, (I), and 4‐aminopyridinium nicotinate, C₅H₇N₂⁺·C₆H₄NO₂⁻, (II), the aromatic N atoms of the 4‐aminopyridinium cations are protonated. In (I), the asymmetric unit is composed of two 4‐aminopyridinium cations, two 4‐aminobenzoate anions and four water molecules, and the compound crystallizes in a noncentrosymmetric space group. The two sets of independent molecules of (I) are related by a centre of symmetry which is not part of the space group. In (I), the protonated pyridinium ring H atoms are involved in bifurcated hydrogen bonding with carboxylate O atoms to form an R₁²(4) ring motif. The water molecules link the ions to form a two‐dimensional network along the (10) plane. In (II), an intramolecular bifurcated hydrogen bond generates an R₁²(4) ring motif and inter‐ion hydrogen bonding generates an R₄²(16) ring motif. The packing of adduct (II) is consolidated via N—H...O and N—H...N hydrogen bonds to form a two‐dimensional network along the (10) plane.     

3,17‐Dioxoandrost‐4‐en‐4‐yl acetate

The title compound, C₂₁H₂₈O₄, has a 4‐acetoxy substituent positioned on the steroid α face. The six‐membered ring A assumes a conformation intermediate between 1α,2β‐half chair and 1α‐sofa. A long Csp³—Csp³ bond is observed in ring B and reproduced in quantum‐mechanical ab initio calculations of the isolated molecule using a molecular‐orbital Hartree–Fock method. Cohesion of the crystal can be attributed to van der Waals interactions and weak C—H...O hydrogen bonds.     

(Z)‐7‐Chloro‐3‐[(3‐chloro­phenyl)­methyl­idene]‐4‐p‐tosyl‐3,4‐di­hydro‐2H‐1,4‐benzoxazine

In the title compound, C₂₂H₁₇Cl₂NO₃S, the mol­ecule is a substituted 3,4‐di­hydro‐2H‐1,4‐benzoxazine compound which has three phenyl rings which are essentially planar. The 3,4‐di­hydro‐2H‐oxazine part of the mol­ecule is fused to the benzo ring and has a half‐boat conformation; the dihedral angle between the planar part of the oxazine ring and the benzo ring is 10.2 (2)°. The (3‐chloro­phenyl)­methyl­idene substituent has a Z configuration in relation to the ring N atom of the oxazine moiety. Interestingly, the p‐toluenesulfonyl (p‐tosyl) substituent on the ring N atom protrudes away from the 3‐­chloro­phenyl substituent thus avoiding any steric interaction.     

3‐O‐Acetyl‐4‐deoxy‐4‐iodo‐β‐d‐fructo­furan­osyl 2,3,6‐tri‐O‐acetyl‐4‐chloro‐4‐deoxy‐α‐d‐gluco­pyran­oside

At 160 K, the gluco­pyran­osyl ring of the title compound, C₂₀H₂₈ClIO₁₃, has a near‐ideal ⁴C₁ conformation and the fructo­furan­osyl ring has a twist ⁴T₃ conformation. The two hydroxy groups are involved in intra‐ and intermolecular hydrogen bonds, with the latter interactions linking the mol­ecules into infinite one‐dimensional chains. The absolute configuration of the mol­ecule has been determined.     

3β‐(1‐Allyl‐1‐pyrrolidinio)‐16‐(2‐pyridylmethylene)androst‐5‐en‐17β‐ol bromide hemihydrate

The title compound, C₃₂H₄₅N₂O⁺·Br^?·0.5H₂O, has the outer two six‐membered rings in chair conformations, while the central ring is in an 8β,9α‐half‐chair conformation. The five‐mem­bered ring of the steroid nucleus adopts a slightly deformed 14α‐envelope conformation. The pyridyl­methyl­ene moiety has an E configuration with respect to the hydroxyl group at position 17. The structure is stabilized by a network of O—H?Br‐type intermolecular hydrogen bonds.     

4‐[2‐(4‐Cyano­phenyl)ethenyl]‐N‐methyl­pyridinium tetra­phenyl­borate

In the title compound, C₁₅H₁₃N₂⁺·C₂₄H₂₀B⁻, the pyridyl ring of the cation makes a dihedral angle of 1.6° with the benzene ring. Each is rotated in the same direction with respect to the central –C—CH=CH—C– linkage, by 3.8 and 5.3°, respectively. The anions have a slightly distorted tetra­hedral geometry. Mol­ecular packing analysis was carried out using the packing energy portioning scheme in the program OPEC. Around each anion in the crystal structure there are eight anions, which inter­act with the central anion through C—H⋯π inter­actions. The cations are hydrogen bonded in a head‐to‐tail fashion, forming chains along [10].     

trans‐4‐[4‐(Dimethylamino)phenyl­iminomethyl]‐N‐phenylpyridinium hexafluorophosphate

The crystal structure of the dipolar chromophoric title compound, C₂₀H₂₀N₃⁺·PF₆^?, is described. The phenyl­ene and pyridyl rings are almost coplanar [dihedral angle 7.5 (2)°], but the phenyl substituent forms a dihedral angle of 56.6 (1)° with the pyridyl ring. The compound crystallizes in the non‐centrosymmetric space group Cc and is a likely candidate for the display of quadratic non‐linear optical effects.     

3‐Benzyl‐2‐(4‐fluorophenyl)‐1,3‐thiazolidin‐4‐one

The title compound, C₁₆H₁₄FNOS, crystallizes with Z′ = 2 in the space group P2₁/c. In one of the two independent molecules, the heterocyclic ring is effectively planar, but in the other molecule this ring adopts an envelope conformation. The molecules are weakly linked by two C—H...O hydrogen bonds to form C₂²(14) chains. Comparisons are made with some symmetrically substituted 2‐aryl‐3‐benzyl‐1,3‐thiazolidin‐4‐ones.     

3,4,6‐Tri‐O‐acetyl‐1,2‐O‐[1‐(exo‐ethoxy)ethylidene]‐β‐d‐mannopyranose 0.11‐hydrate

The title compound, C₁₆H₂₄O₁₀·0.11H₂O, is a key intermediate in the synthesis of 2‐deoxy‐2‐[¹⁸F]fluoro‐d ‐glucose (¹⁸F‐FDG), which is the most widely used molecular‐imaging probe for positron emission tomography (PET). The crystal structure has two independent molecules (A and B) in the asymmetric unit, with closely comparable geometries. The pyranose ring adopts a ⁴C₁ conformation [Cremer–Pople puckering parameters: Q = 0.553 (2) Å, θ = 16.2 (2)° and ϕ = 290.4 (8)° for molecule A, and Q = 0.529 (2) Å, θ =15.3 (3)° and ϕ = 268.2 (9)° for molecule B], and the dioxolane ring adopts an envelope conformation. The chiral centre in the dioxolane ring, introduced during the synthesis of the compound, has an R configuration, with the ethoxy group exo to the mannopyranose ring. The asymmetric unit also contains one water molecule with a refined site‐occupancy factor of 0.222 (8), which bridges between molecules A and B via O—H...O hydrogen bonds.     

4‐[2‐(3‐Methoxyphenyl)ethenyl]‐N‐methylpyridinium tetraphenylborate

In the title compound, C₁₅H₁₆NO⁺·C₂₄H₂₀B⁻, the pyridinium ring of the cation makes a dihedral angle of 4.3 (2)° with the benzene ring. Each is rotated in the same direction with respect to the central C—CH=CH—C linkage, by 10.0 (2) and 7.8 (2)°, respectively. The anions have a slightly distorted tetrahedral geometry. The most interesting feature of the structure is that the anions form a honeycomb‐like hexagonal structure down the b axis through C—H...π interactions. The hexagon is constructed from six BPh₄⁻ anions. The cations interact in a head‐to‐tail fashion along [010], forming chains, and pack antiparallel inside the above honeycomb‐like structure through C—H...π interactions.     

1‐Methyl‐1H‐imidazo[4,5‐f]quinolin‐6‐ium chloride monohydrate

The title compound, C₁₁H₁₀N₃⁺·Cl^?·H₂O, belongs to the N1‐methyl‐substituted imidazo­[4,5‐f]­quinoline family, in which the heterocyclic ring is protonated at the pyridine rather than at the imidazole N atom. The mol­ecule as a whole is almost exactly planar. The molecular structure has been compared with that of the 2‐amino analogue described in the literature, and it was found that the extra amino group of the latter is involved in conjugation with the adjacent double bond, i.e. the conjugation does not extend over the entire heterocyclic system. The cation of the title compound forms a strong hydrogen bond with the Cl^? anion and the anions are interconnected by the water solvent mol­ecule.     

Powder X‐ray study of racemic (2RS,3RS)‐5‐amino‐3‐[4‐(3‐methoxyphenyl)piperazin‐1‐yl]‐1,2,3,4‐tetrahydronaphthalen‐2‐ol

The structure of the title benzovesamicol analogue, C₂₁H₂₇N₃O₂, an important compound for the diagnosis of Alzheimer's disease, has been determined by X‐ray powder diffraction. The title compound was firstly synthesized and characterized by spectroscopic methods (FT–IR, and ¹³C and ¹H NMR). The compound is a racemic mixture of enantiomers which crystallizes in the monoclinic system in a centrosymmetric space group (P2₁/c). Crystallography, in particular powder X‐ray diffraction, was pivotal in revealing that the enantio‐resolution did not succeed. The piperazine ring is in a chair conformation, while the cyclohexene ring assumes a half‐chair conformation. The crystal packing is dominated by intermolecular O—H...N hydrogen bonding which links molecules along the c direction.     

Racemic isopropyl 1,4‐dihydro‐2,6‐dimethyl‐4‐(6‐methyl‐2‐pyridyl)‐3‐nitropyridine‐5‐carboxylate hemi­benzene solvate

This analysis establishes the rotameric orientation of the pyridyl‐ring N atom of the title compound, C₁₇H₂₁N₃O₄·0.5C₆H₆, as antiperiplanar (ap) to the 1,4‐dihydropyridine H‐4, the absence of an intramolecular hydrogen bond between the 1,4‐dihydropyridine NH and the pyridyl‐N atom, and the unusual planarity of the 1,4‐dihydropyridine ring.     

2,3‐Dihydro‐3,3‐dimethylspiro[1H‐4‐oxanthracene‐5,2′‐oxiran]‐10(5H)‐one

The central six‐membered ring in the title compound, C₁₆H₁₆O₃, is almost planar (and almost coplanar with the aromatic ring), despite one of its C atoms being formally sp³ hybridized. The planarity is a consequence of the C atom at the centre of the spiro­cyclic system also being part of the three‐membered epoxide ring. The mol­ecules are linked by π–­π and C—H?π interactions.     

4‐(3,5‐Dimethyl‐1H‐pyrazol‐4‐ylmethyl)‐3,5‐dimethyl‐1H‐pyrazol‐2‐ium dihydrogen phosphate: a combined X‐ray and DFT study

The molecular structure of the title salt, C₁₁H₁₇N₄⁺·H₂PO₄⁻, has been determined from single‐crystal X‐ray analysis and compared with the structure calculated by density functional theory (DFT) at the BLYP level. The crystal packing in the title compound is stabilized primarily by intermolecular N—H...O, O—H...N and O—H...O hydrogen bonds and π–π stacking interactions, and thus a three‐dimensional supramolecular honeycomb network consisting of R₄²(10), R₄⁴(14) and R₄⁴(24) ring motifs is established. The HOMO–LUMO energy gap (1.338 eV; HOMO is the highest occupied molecular orbital and LUMO is the lowest unoccupied molecular orbital) indicates a high chemical reactivity for the title compound.     

β‐1‐Acet­amido‐4‐O‐β‐d‐galacto­pyranosyl‐d‐gluco­pyran­ose dihydrate

The crystal structure of the title compound, C₁₄H₂₅NO₁₁·2H₂O, has been determined. The glucose and galactose residues are in a ⁴C₁ conformation. The N‐acetyl group has a Z‐anti conformation.     

Di­spiro­[fluorene‐9,5′‐[1,2,3,4]­tetra­thia­ne‐6′,9′′‐fluorene]

The tetra­thia­ne ring of the title compound, C₂₆H₁₆S₄, has a chair conformation and the mol­ecule has approximate C₂ symmetry. Each of the two fluorene ring systems is virtually planar, with the ring planes intersecting at an angle of 67.58 (5)°. This novel compound has been formed as a side product from the treatment of 9H‐fluorene‐9‐thione with methyl N‐[(benzyl­idene)­phenyl]­glycinate in the presence of LiBr and 1,6‐di­aza­bi­cyclo­[5.4.0]­un­decane.     

2,6‐Dimethyl‐1,4‐benzoquinone 4‐monooxime

Mol­ecules of the title compound, C₈H₉NO₂, are linked into sheets by a combination of C—H·N, O—H·N and O—H·O hydrogen bonds and C—H·π inter­actions. The hydrogen bonds are arranged as described by the graph‐set ring notations R₂²(7) and R₃³(5), and a C8 chain motif. There are two planar symmetry‐independent mol­ecules in the asymmetric unit, with a dihedral angle of 19.24 (5)° between their least‐squares mean planes.     

4‐(3,17‐Dioxoandrost‐4‐en‐16‐ylidenemethyl)benzonitrile

The title compound, C₂₇H₂₉NO₂, has the outer six‐membered ring in a sofa conformation, while the central rings are in chair conformations. The five‐membered ring adopts a slightly distorted 13β,14α‐half‐chair conformation. The cyano­benzyl­idene moiety has an E configuration with respect to the carbonyl group at position 17.     

A synchrotron study of (2R,5′S)‐5′‐benzyl‐5‐bromo‐6‐methoxyspiro[indane‐2,2′‐piperazine]‐3′,6′‐dione dimethylformamide solvate

Synchrotron radiation was used to study the structure of the title compound, C₂₀H₁₉BrN₂O₃·C₃H₇NO, which was obtained as fine fragile needle‐shaped crystals by recrystallization from dimethylformamide (DMF), one molecule of which is incorporated per asymmetric unit into the crystal. The compound adopts a compact closed conformation with the orientation of the benzyl group such that the aryl ring is positioned over the piperazinedione ring, resulting in a C_spiro...C_trans—C—C_Ph pseudo‐torsion angle of −3.3 (3)°. The five‐membered ring is present in an expected envelope conformation and the six‐membered piperazinedione ring adopts a less puckered boat‐like conformation. Reciprocal amide‐to‐amide hydrogen bonding between adjacent piperazinedione rings and C—H...O interactions involving DMF molecules propagate in the crystal as a thick ribbon in the a‐axis direction.